These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 26371843)

  • 1. Sublingual grass and ragweed immunotherapy: Clinical considerations-a PRACTALL consensus report.
    Li JT; Bernstein DI; Calderon MA; Casale TB; Cox L; Passalacqua G; Pfaar O; Papadopoulos NG
    J Allergy Clin Immunol; 2016 Feb; 137(2):369-76. PubMed ID: 26371843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epinephrine Use in Clinical Trials of Sublingual Immunotherapy Tablets.
    Nolte H; Casale TB; Lockey RF; Fogh BS; Kaur A; Lu S; Nelson HS
    J Allergy Clin Immunol Pract; 2017; 5(1):84-89.e3. PubMed ID: 27838323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequential Treatment Initiation with Timothy Grass and Ragweed Sublingual Immunotherapy Tablets Followed by Simultaneous Treatment Is Well Tolerated.
    Maloney J; Berman G; Gagnon R; Bernstein DI; Nelson HS; Kleine-Tebbe J; Kaur A; Li Q; Nolte H
    J Allergy Clin Immunol Pract; 2016; 4(2):301-9.e2. PubMed ID: 26755098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent development on the use of sublingual immunotherapy tablets for allergic rhinitis.
    Waserman S; Shah A; Avilla E
    Ann Allergy Asthma Immunol; 2021 Aug; 127(2):165-175.e1. PubMed ID: 34029713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A practical guide to the sublingual immunotherapy tablet adverse event profile: implications for clinical practice.
    Bernstein DI; Bardelas JA; Svanholm Fogh B; Kaur A; Li Z; Nolte H
    Postgrad Med; 2017 Aug; 129(6):590-597. PubMed ID: 28326906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sublingual immunotherapy in children: the recent experiences.
    Pleskovic N; Bartholow A; Skoner DP
    Curr Opin Allergy Clin Immunol; 2014 Dec; 14(6):582-90. PubMed ID: 25188717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sublingual Immunotherapy Dosing Regimens: What Is Ideal?
    Jin JJ; Li JT; Klimek L; Pfaar O
    J Allergy Clin Immunol Pract; 2017; 5(1):1-10. PubMed ID: 28065336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical efficacy of sublingual immunotherapy tablets for allergic rhinitis is unlikely to be derived from
    Canonica GW; Devillier P; Casale T; Demoly P; Bos C; Karagiannis E; Passalacqua G; Wahn U; Mascarell L
    Expert Rev Clin Immunol; 2019 Sep; 15(9):921-928. PubMed ID: 31403823
    [No Abstract]   [Full Text] [Related]  

  • 9. Persistence of treatment with 5-grass pollen tablets in patients with allergic rhinitis: a real-life study.
    Ras L; de Groot H; Stengs CH; van Weissenbruch R
    Ann Allergy Asthma Immunol; 2016 Jan; 116(1):52-58.e2. PubMed ID: 26596408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sublingual or subcutaneous immunotherapy for allergic rhinitis?
    Durham SR; Penagos M
    J Allergy Clin Immunol; 2016 Feb; 137(2):339-349.e10. PubMed ID: 26853126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical benefits of treatment with SQ house dust mite sublingual tablet in house dust mite allergic rhinitis.
    Demoly P; Kleine-Tebbe J; Rehm D
    Allergy; 2017 Oct; 72(10):1576-1578. PubMed ID: 28273339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ragweed allergy immunotherapy tablet MK-3641 (Ragwitek®) for the treatment of allergic rhinitis.
    Nelson HS
    Expert Rev Clin Immunol; 2018 Dec; 14(12):1003-1011. PubMed ID: 30345820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and tolerability of 5-grass pollen tablet sublingual immunotherapy: pooled analysis and clinical review.
    Didier A; Bons B
    Expert Opin Drug Saf; 2015 May; 14(5):777-88. PubMed ID: 25732009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Onset and dose-related efficacy of house dust mite sublingual immunotherapy tablets in an environmental exposure chamber.
    Nolte H; Maloney J; Nelson HS; Bernstein DI; Lu S; Li Z; Kaur A; Zieglmayer P; Zieglmayer R; Lemell P; Horak F
    J Allergy Clin Immunol; 2015 Jun; 135(6):1494-501.e6. PubMed ID: 25636947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of sublingual immunotherapy Timothy grass tablet in subjects with allergic rhinitis with or without conjunctivitis and history of asthma.
    Maloney J; Durham S; Skoner D; Dahl R; Bufe A; Bernstein D; Murphy K; Waserman S; Berman G; White M; Kaur A; Nolte H
    Allergy; 2015 Mar; 70(3):302-9. PubMed ID: 25495666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Consistent efficacy and safety of sublingual immunotherapy tablets across allergens and geographic regions.
    Stranzl T; Bernstein DI; Matsuoka T; Durham S; Maekawa Y; Sejer Andersen P; Nolte J; Hulstrom V; Nolte H
    Allergy Asthma Proc; 2024 Jul; 45(4):232-239. PubMed ID: 38760164
    [No Abstract]   [Full Text] [Related]  

  • 17. Five-grass-pollen sublingual immunotherapy tablet for the treatment of grass-pollen-induced allergic rhinoconjunctivitis: 5 years of experience.
    Didier A; Wahn U; Horak F; Cox LS
    Expert Rev Clin Immunol; 2014 Oct; 10(10):1309-24. PubMed ID: 25205329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tablet-based sublingual immunotherapy for respiratory allergy.
    Prieto L
    Allergol Immunopathol (Madr); 2017 Dec; 45 Suppl 1():30-35. PubMed ID: 29146015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose-finding study of carbamylated monomeric allergoid tablets in grass-allergic rhinoconjunctivitis patients.
    Mösges R; Rohdenburg C; Eichel A; Zadoyan G; Kasche EM; Shah-Hosseini K; Lehmacher W; Schmalz P; Compalati E
    Immunotherapy; 2017 Nov; 9(15):1225-1238. PubMed ID: 29130797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sublingual immunotherapy: current concepts for the U.S. practitioner.
    Lin SY
    Int Forum Allergy Rhinol; 2014 Sep; 4 Suppl 2():S55-9. PubMed ID: 25182357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.